FDA Inspection
Ultragenyx Pharmaceutical Inc.Ultragenyx Pharmaceutical Inc. – FDA Inspection, Jul 17, 2025
Record Details
This FDA Inspection record concerns Ultragenyx Pharmaceutical Inc., with an inspection on July 17, 2025, issued by the Center for Drug Evaluation and Research, covering drugs.
View Company Profile
ID · 5630a73e-826a-4c90-b3a6-9bd1313a6920
Inspection Facts
No Action Indicated (NAI)
No objectionable conditions or practices were found during the inspection.
- Inspection number
- 1277227
- FDA center
- Human Drugs
- Project area
- Drug Quality Assurance
Other FDA inspections of Ultragenyx Pharmaceutical Inc.
2| Date | Classification | Office | Project area |
|---|---|---|---|
| February 27, 2023 | NAI | Center for Drug Evaluation and Research | Bioresearch Monitoring |
| June 20, 2017 | VAI | Center for Drug Evaluation and Research | Bioresearch Monitoring |
Other documents for Ultragenyx Pharmaceutical Inc.
- FDA Inspection 1199790 - 2023-02-27
- FDA Inspection 1015263 - 2017-06-20
Document or profile
One record shows the event. A profile shows the pattern.
Buy this document for the source file and details behind this single event.
Choose full profile access to connect related records, sites, people, citations, and enforcement history in one view.